| 文拉法辛缓释剂与阿米替林治疗躯体形式障碍对照研究 |
| |
| 引用本文： | 杨梅,王得燧.文拉法辛缓释剂与阿米替林治疗躯体形式障碍对照研究[J].中国健康心理学杂志,2011,19(9):1025-1026. |
| |
| 作者姓名： | 杨梅 王得燧 |
| |
| 作者单位： | 中国,四川广元市精神卫生中心,628000 |
| |
| 摘 要： | 目的 了解文拉法辛缓释剂治疗躯体形式障碍的疗效和不良反应.方法 将64例患者随机分为研究组和对照组,研究组服用文拉法辛缓释剂,对照组服用阿米替林,分别治疗6周,采用症状自评量表(SCL-90)和副反应量表(TESS)评定疗效和不良反应.结果 在治疗第2周时抑郁因子和焦虑因子评分研究组同对照组相比差异有统计学意义(t=2...
|
| 关 键 词： | 躯体形式障碍 文拉法辛缓释剂 阿米替林 症状自评量表 |
Control Study on Venlafaxine XR vs Amitriptyline in the Treatment of Somatoform Disorders |
| |
| Yang Mei,Wang Desui.Control Study on Venlafaxine XR vs Amitriptyline in the Treatment of Somatoform Disorders[J].china journal of health psychology,2011,19(9):1025-1026. |
| |
| Authors: | Yang Mei Wang Desui |
| |
| Institution: | Yang Mei,Wang Desui.Guang Yuan Mental Health Center,Guang Yuan,Sichuan 628000,P.R.China |
| |
| Abstract: | Objective To explore the curative effects and adverse effects of Venlafaxine XR in the treatment of somatoform disorders.Methods A total of 64 patients with somatoform disorders were randomly divided into research group receiving Venlafaxine XR and control group doing Amitriptyline for 6 weeks respectively.The curative effects were assessed with Symptom Checklist 90(SCL-90) and adverse effects with Treatment Emergent Symptom Scale(TESS).Results At the end of the 2nd week,there was statistical difference on ... |
| |
| Keywords: | Somatoform disorders Venlafaxine XR Amitriptyline SCL-90 |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
